Abdülbaki Kumbasar
-
- Paraoxonase enzyme and polymorphisms 4
-
- Dialysis and Renal Disease Management 3
-
- Biomarkers in Disease Mechanisms 3
-
- Atrial Fibrillation Management and Outcomes 3
-
- COVID-19 Clinical Research Studies 3
-
- Pancreatitis Pathology and Treatment 3
-
- Hormonal and reproductive studies 3
-
- Adipokines, Inflammation, and Metabolic Diseases 3
- Co-authors
- Özlem HarmankayaAliye SoyluYıldız OkuturlarNurgül YaşarMustafa KalaycıRümeyza KazancıoğluMeral GünaldıÖmür Tabak
- Journals
- SHILAP Revista de lepidopterología (2 papers)European Radiology (1 paper)Cytokine (1 paper)
- Partner nations
- TürkiyeUnited States
In The Last Decade
Abdülbaki Kumbasar
40 papers receiving 350 citations
Peers
Comparison fields: 5 of 73
- Clinical Biochemistry 28
- Nephrology 25
- Oncology 93
- Hepatology 21
- Obstetrics and Gynecology 20
Countries citing papers authored by Abdülbaki Kumbasar
This map shows the geographic impact of Abdülbaki Kumbasar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdülbaki Kumbasar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdülbaki Kumbasar more than expected).
Fields of papers citing papers by Abdülbaki Kumbasar
This network shows the impact of papers produced by Abdülbaki Kumbasar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdülbaki Kumbasar. The network helps show where Abdülbaki Kumbasar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abdülbaki Kumbasar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 11 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 2 | |
| 5 | 2019 | 35 | |
| 6 | 2019 | 2 | |
| 7 | 2018 | 12 | |
| 8 | 2017 | 3 | |
| 9 | 2016 | 5 | |
| 10 | 2016 | 4 | |
| 11 | 2015 | 52 | |
| 12 | 2014 | 13 | |
| 13 | 2012 | 11 | |
| 14 | 2011 | 0 | |
| 15 | Sağlık personelinin yaşam kalitesi üzerine kesitsel bir çalışma | 2011 | 3 |
| 16 | 2009 | 19 | |
| 17 | 2009 | 9 | |
| 18 | 2008 | 45 | |
| 19 | 2007 | 14 | |
| 20 | 2004 | 15 |
About Abdülbaki Kumbasar
Abdülbaki Kumbasar is a scholar working on Clinical Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 44 papers that have together received 361 indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (4 papers), Biomarkers in Disease Mechanisms (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), COVID-19 Clinical Research Studies (3 papers), Pancreatitis Pathology and Treatment (3 papers), Dialysis and Renal Disease Management (3 papers), Hormonal and reproductive studies (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Clinical Biochemistry (28 citations), Nephrology (25 citations) and Oncology (93 citations). Abdülbaki Kumbasar has collaborated with scholars based in Türkiye and United States. Frequent co-authors include Özlem Harmankaya, Aliye Soylu, Yıldız Okuturlar, Nurgül Yaşar, Mustafa Kalaycı, Rümeyza Kazancıoğlu, Meral Günaldı, Ömür Tabak, Hafize Uzun and Kemal Dolay. Their work appears in journals such as SHILAP Revista de lepidopterología, European Radiology and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.